Published in Cardiovasc Diabetol on April 01, 2011
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Importance of cardiovascular disease risk management in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes (2014) 1.05
Aspirin in primary prevention of cardiovascular disease and cancer: a systematic review of the balance of evidence from reviews of randomized trials. PLoS One (2013) 1.03
Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status. PLoS One (2014) 0.98
A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007). Langenbecks Arch Surg (2011) 0.86
Aspirin for primary prevention of cardiovascular disease. Thromb J (2015) 0.82
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: An Overview of Systematic Reviews. JAMA Cardiol (2016) 0.82
Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study. Cardiovasc Diabetol (2013) 0.78
A systematic review of aspirin in primary prevention: is it time for a new approach? Am J Cardiovasc Drugs (2015) 0.78
Acetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks? Ther Adv Drug Saf (2012) 0.78
Platelet thromboxane (11-dehydro-Thromboxane B2) and aspirin response in patients with diabetes and coronary artery disease. World J Diabetes (2014) 0.76
Low dose of acetylsalicylic acid and oxidative stress-mediated endothelial dysfunction in diabetes: a short-term evaluation. Acta Diabetol (2014) 0.75
Histamine H2 receptor antagonists for decreasing gastrointestinal harms in adults using acetylsalicylic acid: systematic review and meta-analysis. Open Med (2012) 0.75
Approach to preventive care in the elderly. Can Fam Physician (2016) 0.75
[Aborder les soins préventifs chez les aînés]. Can Fam Physician (2016) 0.75
Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24
Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials (1996) 64.38
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med (2009) 35.37
Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med (1998) 25.66
A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med (2005) 17.32
Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med (1989) 13.83
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet (2009) 13.64
How should meta-regression analyses be undertaken and interpreted? Stat Med (2002) 8.96
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA (2008) 6.15
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med (2000) 5.11
Diabetes and decline in heart disease mortality in US adults. JAMA (1999) 4.49
Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care (1998) 4.49
Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials. BMJ (2009) 3.83
Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care (1980) 3.70
Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care (2003) 3.68
Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med (2009) 3.24
Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators. JAMA (1992) 2.52
Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care (2000) 2.34
Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (aspirin)-its relation to metabolic control. Thromb Res (2004) 1.97
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis. Diabetes Res Clin Pract (2009) 1.90
Systematic evaluation and comparison of statistical tests for publication bias. J Epidemiol (2005) 1.35
The impact of prevention on reducing the burden of cardiovascular disease. Diabetes Care (2008) 1.25
AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions. Eur Heart J (2007) 1.12
Thrombolytic therapy for acute ischemic stroke: the likelihood of being helped versus harmed. Stroke (2007) 1.01
Aspirin for the primary prevention of cardiovascular events: a systematic review and meta-analysis comparing patients with and without diabetes. Diabetes Care (2009) 0.98
Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin. J Mol Med (Berl) (2004) 0.97
Role of aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: a meta-analysis. Expert Opin Pharmacother (2010) 0.96
Aspirin and clopidogrel: efficacy and resistance in diabetes mellitus. Best Pract Res Clin Endocrinol Metab (2009) 0.94
Communicating the benefits and harms of treatments. Arch Dis Child (2008) 0.88
Reduction of cardiovascular events and microvascular complications in diabetes with ACE inhibitor treatment: HOPE and MICRO-HOPE. Diabetes Metab Res Rev (2002) 0.88
Antiplatelet agents for the prevention of cardiovascular disease in diabetes mellitus. Am J Cardiovasc Drugs (2004) 0.80
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care (2005) 30.41
The Canadian Adverse Events Study: the incidence of adverse events among hospital patients in Canada. CMAJ (2004) 21.24
Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology (2011) 12.09
Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2007) 7.79
New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol (2004) 7.20
D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med (2004) 6.15
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ (2011) 6.11
Validity of information on comorbidity derived rom ICD-9-CCM administrative data. Med Care (2002) 5.92
Physician wellness: a missing quality indicator. Lancet (2009) 5.50
Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data. Med Care (2004) 5.12
Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med (2006) 4.90
Assessing validity of ICD-9-CM and ICD-10 administrative data in recording clinical conditions in a unique dually coded database. Health Serv Res (2008) 4.25
Validity of procedure codes in International Classification of Diseases, 9th revision, clinical modification administrative data. Med Care (2004) 4.15
The reporting of methodological factors in randomized controlled trials and the association with a journal policy to promote adherence to the Consolidated Standards of Reporting Trials (CONSORT) checklist. Control Clin Trials (2002) 3.62
Adapting the Charlson Comorbidity Index for use in patients with ESRD. Am J Kidney Dis (2003) 3.60
Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis. Arch Intern Med (2012) 3.26
Survival after coronary revascularization in the elderly. Circulation (2002) 3.17
Cost analysis of ongoing care of patients with end-stage renal disease: the impact of dialysis modality and dialysis access. Am J Kidney Dis (2002) 3.06
Early risk of stroke after transient ischemic attack: a systematic review and meta-analysis. Arch Intern Med (2007) 3.06
Dealing with missing data in a multi-question depression scale: a comparison of imputation methods. BMC Med Res Methodol (2006) 2.81
Validation of a case definition to define hypertension using administrative data. Hypertension (2009) 2.74
Characteristics and outcomes of patients with acute myocardial infarction and angiographically normal coronary arteries. Am J Cardiol (2005) 2.69
A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care (2011) 2.60
An observational study found that authors of randomized controlled trials frequently use concealment of randomization and blinding, despite the failure to report these methods. J Clin Epidemiol (2004) 2.58
Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke (2005) 2.50
The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease. J Am Coll Cardiol (2004) 2.32
Hospital and surgeon determinants of carotid endarterectomy outcomes. Arch Neurol (2002) 2.30
Cardiac rehabilitation attendance and outcomes in coronary artery disease patients. Circulation (2012) 2.30
Effectiveness of interventions targeting frequent users of emergency departments: a systematic review. Ann Emerg Med (2011) 2.19
Development of a frailty index for patients with coronary artery disease. J Am Geriatr Soc (2010) 2.18
Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care (2007) 2.14
Outcomes after aortic and mitral valve replacement surgery in Canada: 1994/95 to 1999/2000. Can J Cardiol (2004) 2.11
Defining the optimal treatment of locally advanced esophageal cancer: a systematic review and decision analysis. Ann Thorac Surg (2007) 2.06
Aspirin use and outcomes in a community-based cohort of 7352 patients discharged after first hospitalization for heart failure. Circulation (2006) 2.05
Overview of a formal scoping review on health system report cards. Implement Sci (2010) 1.95
Access to health care among status Aboriginal people with chronic kidney disease. CMAJ (2008) 1.91
The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol (2012) 1.86
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol (2013) 1.85
Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography. Circulation (2011) 1.85
Association of socio-economic status with diabetes prevalence and utilization of diabetes care services. BMC Health Serv Res (2006) 1.80
Sex differences in outcomes after cardiac catheterization: effect modification by treatment strategy and time. JAMA (2004) 1.79
Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med (2008) 1.76
Development and validation of a surname list to define Chinese ethnicity. Med Care (2006) 1.71
Quality of life after coronary revascularization in the elderly. Eur Heart J (2006) 1.66
Multiple imputation versus data enhancement for dealing with missing data in observational health care outcome analyses. J Clin Epidemiol (2002) 1.65
Variation in health services utilization among ethnic populations. CMAJ (2006) 1.64
Population rates of cardiac catheterization and yield of high-risk coronary artery disease. CMAJ (2005) 1.64
Assessing accuracy of diagnosis-type indicators for flagging complications in administrative data. J Clin Epidemiol (2004) 1.62
Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol (2006) 1.58
The Enhancing Secondary Prevention in Coronary Artery Disease trial. CMAJ (2009) 1.57
Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure. Ann Intern Med (2009) 1.56
Systematic review and meta-analysis: anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis. Arthritis Care Res (Hoboken) (2011) 1.55
Women with coronary artery disease report worse health-related quality of life outcomes compared to men. Health Qual Life Outcomes (2004) 1.53
Accuracy of city postal code coordinates as a proxy for location of residence. Int J Health Geogr (2004) 1.52
Venous thromboembolic disease: comparison of the diagnostic process in blacks and whites. Arch Intern Med (2003) 1.51
Public versus private institutional performance reporting: what is mandatory for quality improvement? Am Heart J (2006) 1.50
Acute kidney injury following coronary angiography is associated with a long-term decline in kidney function. Kidney Int (2010) 1.50
Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm (2011) 1.48
Relation of T-axis abnormalities to coronary artery disease and survival after cardiac catheterization. Am J Cardiol (2005) 1.48
Exploring the treatment-risk paradox in coronary disease. Arch Intern Med (2007) 1.48
Prevalence of chronic kidney disease and survival among aboriginal people. J Am Soc Nephrol (2007) 1.47
Renal outcomes associated with invasive versus conservative management of acute coronary syndrome: propensity matched cohort study. BMJ (2013) 1.46
In the dark: the reporting of blinding status in randomized controlled trials. J Clin Epidemiol (2002) 1.45
Rapid evaluation after high-risk TIA is associated with lower stroke risk. Can J Neurol Sci (2009) 1.45
Clinical in-stent restenosis with bare metal stents: is it truly a benign phenomenon? Int J Cardiol (2007) 1.45
Identifying priorities in methodological research using ICD-9-CM and ICD-10 administrative data: report from an international consortium. BMC Health Serv Res (2006) 1.45
Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol (2004) 1.44
Counselling overweight and obese patients in primary care: a prospective cohort study. Eur J Cardiovasc Prev Rehabil (2006) 1.44
Association of postoperative complications with hospital costs and length of stay in a tertiary care center. J Gen Intern Med (2006) 1.42
Venous thromboembolism according to age: the impact of an aging population. Arch Intern Med (2004) 1.41
Individual-level and neighborhood-level income measures: agreement and association with outcomes in a cardiac disease cohort. Med Care (2005) 1.39
Trends in wait times for cardiac revascularization. Can J Cardiol (2011) 1.39
Importance of the imaging modality in decision making about carotid endarterectomy. Neurology (2004) 1.38
Does integrated management of childhood illness (IMCI) training improve the skills of health workers? A systematic review and meta-analysis. PLoS One (2013) 1.37
Variations in rates of appropriate and inappropriate carotid endarterectomy for stroke prevention in 4 Canadian provinces. CMAJ (2004) 1.36
Involving clinical librarians at the point of care: results of a controlled intervention. Acad Med (2011) 1.36
Improved accuracy of co-morbidity coding over time after the introduction of ICD-10 administrative data. BMC Health Serv Res (2011) 1.35
Economic evaluation of sirolimus-eluting stents. CMAJ (2005) 1.32
A comparison of several regression models for analysing cost of CABG surgery. Stat Med (2003) 1.31
Contrast-induced acute kidney injury and risk of adverse clinical outcomes after coronary angiography: a systematic review and meta-analysis. Circ Cardiovasc Interv (2013) 1.29
The intraaortic balloon pump in cardiac surgery. Ann Thorac Surg (2002) 1.29
Use of valve surgery in Canada. Can J Cardiol (2004) 1.28
The development, evolution, and modifications of ICD-10: challenges to the international comparability of morbidity data. Med Care (2010) 1.27
Loop diuretics in the management of acute renal failure: a systematic review and meta-analysis. Crit Care Resusc (2007) 1.26
A systematic review of tools for predicting severe adverse events following patient discharge from intensive care units. Crit Care (2013) 1.26
The relative importance of barriers to the prescription of warfarin for nonvalvular atrial fibrillation. Can J Cardiol (2003) 1.25
Application of patient safety indicators internationally: a pilot study among seven countries. Int J Qual Health Care (2009) 1.25
Increasing rates of angioplasty versus bypass surgery in Canada, 1994-2005. Am Heart J (2010) 1.24
Impact of a patient decision aid on care among patients with nonvalvular atrial fibrillation: a cluster randomized trial. CMAJ (2005) 1.22
In search of 'truth' and standards for reporting cardiac procedure waiting times. Can J Cardiol (2006) 1.20
Survival after coronary revascularization among patients with kidney disease. Circulation (2004) 1.19
Diagnostic cardiac catheterization and revascularization rates for coronary heart disease. Can J Cardiol (2004) 1.19
Detailed cost analysis of care for survivors of severe sepsis. Crit Care Med (2004) 1.19
Ordinal regression model and the linear regression model were superior to the logistic regression models. J Clin Epidemiol (2006) 1.17
Addressing cost-related barriers to prescription drug use in Canada. CMAJ (2013) 1.16